Rapid Sterility Testing Market Research Report-Global Forecast till 2027

Rapid Sterility Testing Market Research Report by Product (Kits & Reagents, Instruments, Services), Technology (Membrane Filtration, ATP Bioluminescence), Application (Pharmaceutical and Biological Manufacturing, Medical Device) and Region - Global Forecast till 2027

ID: MRFR/LS/5158-HCR | February 2021 | Region: Global | 100 pages

Rapid Sterility Testing Market Scenario


Rapid Sterility Testing Market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 158 million in 2017 and is projected to grow at a CAGR of 13.4% over the forecast period. Rapid sterility testing used to detect microbial contamination in given biologic sample. It is an alternative method for sterility testing.


The factors such as Increasing R&D expense and new product launches are expected to propel the growth of the market. However, availability of alternative traditional method hampers the market growth over the forecast period.


Rapid Sterility Testing Market Segmentation


The rapid sterility testing market has been segmented into product, technology, and application.


Based on product, market segmented into kits & reagents, instruments, and services. The biological kits & reagents segment is expected to account for the largest share segment of the market in 2017.


Based on technology, has been segmented into membrane filtration, ATP bioluminescence, and other technologies.


Based on application, market segmented into pharmaceutical and biological manufacturing, medical device manufacturing, other end users.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rapid sterility testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European rapid sterility testing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The rapid sterility testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rapid sterility testing market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


Charles River Laboratories, Inc. (US), Gibraltar Laboratories (US), Merck KGaA (Germany), Rapid Micro Biosystems, Inc. (US), bioMérieux (France), Eurofins Scientific (Luxembourg), Becton, Dickinson and Company (US), FOCUS Laboratories (US), Sartorius AG (Germany), and Thermo Fisher Scientific (US) are some of the key players in the rapid sterility testing market.


Regional Market Summary


Rapid Sterility Testing Market Share (%), by Region, 2017


Global Rapid Sterility Testing Market Share (%), by Region, 2017


Source: Annual Reports and Sec filings


Geographically, the Americas is anticipated to dominate the rapid sterility testing market owing to a well-established player and increased R&D expenses.


Europe is expected to hold the second largest position in the rapid sterility testing market. The market growth in this region is attributed to the growth in the pharmaceutical and medical device industry.


The rapid sterility testing market in the Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the increasing adoption of these products.


The Middle East & Africa has the least share of the market.


Market of Rapid Sterility Testing, by Product



  • Kits & Reagents

  • Instruments

  • Services


Market of Rapid Sterility Testing, by Technology



  • Membrane Filtration

  • ATP Bioluminescence

  • Others


Market of Rapid Sterility Testing, by Application



  • Pharmaceutical and Biological Manufacturing

  • Medical Device Manufacturing

  • Others


Market of Rapid Sterility Testing, by Region



  • Americas


    • North America


      • US

      • Canada


    • South America




  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe




  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Rapid Sterility Testing Market, by Key Players



  • Charles River Laboratories, Inc. (US)

  • Merck KGaA (Germany)

  • Rapid Micro Biosystems, Inc. (US)

  • bioMérieux (France)

  • Sartorius AG (Germany)

  • Thermo Fisher Scientific (US)

  • Eurofins Scientific (Luxembourg)

  • Becton, Dickinson and Company (US)

  • FOCUS Laboratories (US)

  • Gibraltar Laboratories (US)


Intended Audience



  • Rapid sterility testing Manufacturers and vendors

  • Rapid sterility testing service providers

  • Various research and consulting firms

  • Pharmaceutical and Biotech companies

  • Medical device companies



Frequently Asked Questions (FAQ) :


Rapid Sterility Testing Market, as of 2017, is valued at USD 158 million.

Rapid Sterility Testing Market has a chance to grow with a 13.4% CAGR show during the forecast period of 2018 to 2023.

Hike in research and development projects, better innovation and launching plans of products, and a rising acceptance rate of the test can trigger the growth rate of the Rapid Sterility Testing Market.

Global Rapid Sterility Testing Market accepts segments like ATP bioluminescence, membrane filtration, and other technologies.

End users like pharmaceutical and biological manufacturing, medical device manufacturing, other end users would encourage growth for the Rapid Sterility Testing Market.